Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.

Pharmacogenetics and genomics - 1 Sept 2007

Ashton Lesley J, Murray Jayne E, Haber Michelle, Marshall Glenn M, Ashley David M, Norris Murray D

Abstract excerpt

BACKGROUND: Although several studies have shown that drug metabolizing enzyme gene polymorphisms may influence the impact of therapy in childhood leukemia, no comprehensive investigations have been carried out in children with neuroblastoma. The aim of this study was to identify polymorphisms in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Cytochrome P-450 Enzyme System
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to N-Myc Proto-Oncogene Protein

Share to Neuroblastoma

Share to Oncogene Proteins

Share to Pharmaceutical Preparations

Source

Identifiers

PMID: 17700360
DOI: 10.1097/FPC.0b013e3280e1cc92

Genes

NAT1
GSTM1
MYCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17700360-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.PMID 17700360Read ↗

Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.Semantic proximity Read ↗

Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.Semantic proximity Read ↗

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?Semantic proximity Read ↗

Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.Semantic proximity Read ↗

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Semantic proximity Read ↗

Genetic predisposition and treatment-related leukemia.Semantic proximity Read ↗

Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastomaSemantic proximity Read ↗

Factors Influencing Mortality in Children with Central Nervous System Tumors: A Cohort Study on Clinical Characteristics and Genetic Markers.Semantic proximity Read ↗

Phase I and Phase II enzyme polymorphisms and childhood cancer.Semantic proximity Read ↗

Glutathione transferase P1 polymorphism in neuroblastoma studied by endonuclease restriction mapping.Semantic proximity Read ↗

Cohort-Based Association Study Association of Genetic Variations of ABCC with the Non-Response and Relapse of Pediatric Patients with Central Nervous System TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.